So, when will Neuralink be available? The company says it will begin human trials this year, but the exact date is a mystery. Musk has not responded to requests for comment. But, he has promised that the technology will be available soon. While Musk has been cautious with his products, he has shown a real commitment to the project. That’s why Neuralink is being tested on monkeys and is slated for human trials by the end of the year.
While Musk’s Tesla and SpaceX companies are in the early stages of development, he isn’t the only one worried about the technology’s long-term success. The founders of Neuralink have raised over $300 million in venture funding. While the funding was initially modest, the company is already hiring to help with clinical trials. The hiring of a clinical trial director is the first step toward FDA approval.
The device would be implanted into a patient’s brain. The chip would simultaneously record and stimulate brain activity. It’s intended for use in neurological disorders and spinal-cord injuries. Musk hopes to be able to use this technology in humans by 2020. Musk has revealed that the chip could improve the quality of life for people with disabilities or injuries, such as those with epilepsy and Parkinson’s disease.
As the name suggests, Neuralink is a brain-computer interface that connects to the brain. The system uses an array of electrode threads to capture data from the brain. It’s small enough to replace part of the skull without damaging the brain. Future versions of the device would have all-day battery life. It will be able to read brain waves and send commands. The device could be implanted into the skull, which would be the easiest part to install.
As the clinical trial director of Neuralink, you’ll be working with top engineers and innovative doctors to develop this new technology. As a clinical trial director, you’ll be dealing with patients and regulatory agencies, and you’ll be able to interact with the first participants in the clinical trials. You will also be working with the company’s CEO, Elon Musk. And he isn’t the only tech billionaire behind Neuralink. His other companies include SpaceX and Tesla.
Neuralink’s goal is to implant brain chips in humans by the year 2022. Musk has previously given earlier estimates, including 2022. However, the company has been testing the technology on monkeys, and claims that the device is ready for human use. This will allow patients with severe spinal cord injuries to regain full functionality. And since the technology has already been tested on animals, the company plans to have it available to patients in 2022.